Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mardi Dier

CFO at Madrigal Pharmaceuticals, Inc. (MDGL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.8M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 64613,826 held (−4%) $431.94 $279K +9.2%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 4013,786 held (−0%) $425.08 $17K +11.0%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 42013,366 held (−3%) $426.86 $179K +10.5%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 8013,286 held (−1%) $427.85 $34K +10.3%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 16013,126 held (−1%) $429.00 $69K +10.0%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 4013,086 held (−0%) $429.58 $17K +9.8%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 12012,966 held (−1%) $430.90 $52K +9.5%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 11612,850 held (−1%) $432.56 $50K +9.1%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 16012,690 held (−1%) $434.20 $69K +8.6%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 8012,610 held (−1%) $435.32 $35K +8.4%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 8012,530 held (−1%) $436.69 $35K +8.0%
Mar 6SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 4012,490 held (−0%) $437.65 $18K +7.8%
Mar 2SEC MDGLMadrigal Pharmaceuticals, Inc. Sell 1,1839,257 held (−11%) $427.21 $505K +10.4%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 32014,293 held (−2%) $570.39 $183K -17.3%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 41013,883 held (−3%) $571.99 $235K -17.5%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 35413,529 held (−3%) $573.02 $203K -17.7%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 71712,812 held (−5%) $574.00 $412K -17.8%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 12012,692 held (−1%) $574.95 $69K -17.9%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 24012,452 held (−2%) $576.15 $138K -18.1%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 32012,132 held (−3%) $577.81 $185K -18.4%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 25811,874 held (−2%) $578.83 $149K -18.5%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 48011,394 held (−4%) $579.85 $278K -18.6%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 24011,154 held (−2%) $585.44 $141K -19.4%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 24010,914 held (−2%) $587.85 $141K -19.7%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 16010,754 held (−1%) $589.65 $94K -20.0%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 16010,594 held (−1%) $590.37 $94K -20.1%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 7410,520 held (−1%) $595.20 $44K -20.7%
Dec 3SEC MDGLMadrigal Pharmaceuticals, Inc. Sell Plan 8010,440 held (−1%) $596.19 $48K -20.9%
  • Sell

    CFO Mardi Dier sold $279K of MDGL at $431.94 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mardi Dier sold $17K of MDGL at $425.08 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mardi Dier sold $179K of MDGL at $426.86 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mardi Dier sold $34K of MDGL at $427.85 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mardi Dier sold $69K of MDGL at $429.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Mardi Dier sold $17K of MDGL at $429.58 — pre-scheduled 10b5-1 plan sale.